Samuel Brady Email & Phone Number

My laboratory brings together cancer genomics and pharmacology to identify new approaches to treat pediatric cancers. My original training (PhD and postdoctoral fellow) was as a bench scientist studying cancer drug resistance and cell signaling. Later, I transitioned into genomics-focused roles analyzing tumor evolution, genomic landscapes, and mutated driver genes.I've been fortunate to work in collaborative teams that have published high-impact work studying large genomic datasets, including:1. Analysis of the genomic landscape of 2,754 acute lymphoblastic leukemias (Brady*, Roberts* et al., Nature Genetics 54:1376-1389 (2022)).2. Elucidating the genomic landscape of 702 neuroblastomas (Brady*, Liu* et al., Nature Communications 11:5183 (2020)).3. Uncovering tumor evolution and drug resistance in 180 relapsed leukemias (Yang*, Brady*, Tang*, Sun*, Du* et al., Nature Cancer 2:819-834 (2021)).4. Studying breast cancer clonal evolution in four multi-sample breast cancers through years of evolution (Brady et al., Nature Communications 8:1231 (2017)).*Equal contribution